RK

Riyazuddin Khan Faridi

Active Director Director DIN 02809131
DIN 02809131 First appointment Nov 2009 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Nov 2009
Shareholding value •••• Premium profile

About Riyazuddin Khan Faridi

Data last updated:

Riyazuddin Khan Faridi is a Director at Microgen Healthcare Private Limited (since 2009) and Director at Corazon Pharma Private Limited (since 2014). The companies operate in FMCG and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹65.03 Cr; the largest is Microgen Healthcare Private Limited at ₹64.78 Cr (FY 2025). Earlier, Riyazuddin Khan Faridi was a Director at Chemikerin Technomed Private Limited (from 2021) and Director at Mh Lifescience Private Limited (from 2009) and 1 more.

DIN 02809131
Primary Designation Director
Industry FMCG
First Appointment 27 Nov 2009
Oldest Company Age 20 yrs
Largest company Microgen Healthcare Private Limited · ₹64.78 Cr (FY 2025)
Combined revenue ₹65.03 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Microgen Healthcare Private Limited U24119MH2006PTC164171
Director27 Nov 20092006₹64.78 Cr (FY 2025)Active
Corazon Pharma Private Limited U24100MH2009PTC196106
Director19 Mar 20142009₹25.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemikerin Technomed Private Limited U24290MH2021PTC353691
Director19 Jan 20212021Strike Off
Mh Lifescience Private Limited U73100MH2009PTC196916
Director27 Nov 20092009Strike Off
Microgen Meditech Private Limited U21006MH2024PTC428692
Director12 Jul 20242024Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Corazon Pharma Private Limited
Microgen Healthcare Private Limited
Chemikerin Technomed Private Limited
Mh Lifescience Private Limited
Premium access

Shareholding and investment profile for Riyazuddin Khan Faridi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Riyazuddin Khan Faridi

Riyazuddin Khan Faridi currently holds 2 directorships: Microgen Healthcare Private Limited (Director, since 27 Nov 2009, revenue ₹64.78 Cr (FY 2025)); Corazon Pharma Private Limited (Director, since 19 Mar 2014, revenue ₹25.3 Lakh (FY 2025)).

Riyazuddin Khan Faridi was first appointed on 27 Nov 2009 as Director at Microgen Healthcare Private Limited. The most recent appointment on record is 12 Jul 2024 at Microgen Meditech Private Limited.

The 2 current companies of Riyazuddin Khan Faridi that report revenue have a combined latest revenue of ₹65.03 Cr: Microgen Healthcare Private Limited ₹64.78 Cr (FY 2025); Corazon Pharma Private Limited ₹25.3 Lakh (FY 2025).

Riyazuddin Khan Faridi held 3 earlier board appointments: Chemikerin Technomed Private Limited (Director, from 19 Jan 2021); Mh Lifescience Private Limited (Director, from 27 Nov 2009); Microgen Meditech Private Limited (Director, from 12 Jul 2024).

The current boards of Riyazuddin Khan Faridi's companies include Dilip Iswarlal Parekh (Microgen Healthcare Private Limited), Harshada Abhijit Yemul (Microgen Healthcare Private Limited), Harshada Abhijit Yemul (Microgen Healthcare Private Limited), Jash Dilip Parekh (Microgen Healthcare Private Limited), Pradip Chandrakant Mehta (Microgen Healthcare Private Limited), Rajul Dilip Parekh (Microgen Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available